How can left ventricular hypertrophy be fatal?
How can left ventricular hypertrophy be fatal?
As a result of these changes, complications of left ventricular hypertrophy include: Reduced blood supply to the heart. Inability of the heart to pump enough blood to your body (heart failure)
Is IHSS the same as HCM?
Historically, HCM has been known by a confusing array of names, such as idiopathic hypertrophic subaortic stenosis (IHSS), muscular subaortic stenosis, and hypertrophic obstructive cardiomyopathy (HOCM).
What is the life expectancy of someone with left ventricular hypertrophy?
Research has shown that with proper treatment and follow-ups, most people with HCM live a normal life. A database of 1,297 patients with HCM from the Minneapolis Heart Institute Foundation identified that 2% of the patients can live past 90 years, and 69% of them were women.
Is Ihss genetic?
Analysis of these families indicated that IHSS is transmitted in a non-sex-linked, autosomal dominant fashion, without genetic anticipation. The etiology of IHSS has not been defined.
What is IHSS in Echo?
Idiopathic hypertrophic subaortic stenosis (IHSS) is morphologically characterized by ventricular septal hypertrophy. It is asymmetrical because there is no corresponding hypertrophy of the posterior wall of the ventricle. The proportion between septal thickness and posterior wall thickness is more than 1.2.
What makes hypertrophic cardiomyopathy worse?
Hypertension can worsen the symptoms of HCM, so it’s important to achieve or maintain a healthy blood pressure. Take blood pressure medication as directed by the doctor managing your HCM. This is because some blood pressure medications can worsen obstruction in certain people.
What medication below would you avoid in a patient with hypertrophic obstructive cardiomyopathy Hocm?
Agents to reduce pre- or afterload (such as nitrate, ACE inhibitors, nifedipine-type calcium antagonists) are contraindicated with HOCM due to possible aggravation of the outflow tract obstruction.
What is the prognosis of multiple myeloma?
Doctors may use prognosis to help determine a treatment plan. The five-year survival rate for multiple myeloma in the United States is 55.6 percent. This means that around 55 out of 100 people will live for five years or more after being diagnosed with myeloma. People diagnosed with very early-stage myeloma have better survival rates.
How does multiple myeloma affect the heart?
Direct damage to the heart tissue is a potential short-term or long-term complication from anticancer therapy. Patients with myeloma are at higher risk if they have any of the following: In addition, many therapies for multiple myeloma that prolong overall survival may, paradoxically, expose patients to heart and lung problems.
What is the international staging system for multiple myeloma?
The most commonly used staging system in multiple myeloma is the International Staging System. It is based primarily on two blood test results: beta2-microglobulin (ß2M) and albumin. ß2M is a protein that indicates the extent of disease, while albumin is an indicator of overall general health.
What are the risk factors for multiple myeloma (MM)?
Patients with myeloma are at higher risk if they have any of the following: Family history of heart disease in a first-degree male relative younger than 55 or female younger than 65 In addition, many therapies for multiple myeloma that prolong overall survival may, paradoxically, expose patients to heart and lung problems.
